Chemical Compound Review:
Cuprenil (2R)-2-amino-3-methyl-3- sulfanyl-butanoic...
Synonyms:
Cuprimine, Metalcaptase, penicillamine, Mercaptovaline, D-Penicillamine, ...
Nierkens,
Aalbers,
Bol,
Bleumink,
van Kooten,
Boon,
Pieters,
Fujiwara,
Iso,
Kitanaka,
Kitanaka,
Eguchi,
Ookawara,
Ozawa,
Shimoda,
Yoshihara,
Takemura,
Suzuki,
Sugimoto,
Inoue,
Yamashita,
Takeshita,
Nakaike,
Squitti,
Rossini,
Cassetta,
Moffa,
Pasqualetti,
Cortesi,
Colloca,
Rossi,
Finazzi-Agró,
Nierkens,
van Helden,
Bol,
Bleumink,
van Kooten,
Ramdien-Murli,
Boon,
Pieters,
- HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. Wooley, P.H., Griffin, J., Panayi, G.S., Batchelor, J.R., Welsh, K.I., Gibson, T.J. N. Engl. J. Med. (1980)
- A prospective trial of D-penicillamine in primary biliary cirrhosis. Matloff, D.S., Alpert, E., Resnick, R.H., Kaplan, M.M. N. Engl. J. Med. (1982)
- Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine. Matsubara, T., Saura, R., Hirohata, K., Ziff, M. J. Clin. Invest. (1989)
- D-penicillamine-induced IgA deficiency in Wilson's disease. Proesmans, W., Jaeken, J., Eeckels, R. Lancet (1976)
- Anti-acetylcholine receptor antibodies in D-penicillamine-associated myasthenia gravis. Vincent, A., Newsom-Davis, J., Martin, V. Lancet (1978)
- Efficacy and toxicity of D-penicillamine in low-level lead poisoning. Shannon, M., Graef, J., Lovejoy, F.H. J. Pediatr. (1988)
- d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients. Squitti, R., Rossini, P.M., Cassetta, E., Moffa, F., Pasqualetti, P., Cortesi, M., Colloca, A., Rossi, L., Finazzi-Agró, A. Eur. J. Clin. Invest. (2002)
- Effects of copper metabolism on neurological functions in Wistar and Wilson's disease model rats. Fujiwara, N., Iso, H., Kitanaka, N., Kitanaka, J., Eguchi, H., Ookawara, T., Ozawa, K., Shimoda, S., Yoshihara, D., Takemura, M., Suzuki, K. Biochem. Biophys. Res. Commun. (2006)
- Evaluation of the ability of d-penicillamine to protect rats against the neurotoxicity induced by zinc pyridinethione, acrylamide, 2,5-hexanedione and p-bromophenylacetylurea. LoPachin, R.M., Weiler, M.S., Williams, K.D., Peterson, R.E. Neurotoxicology (1984)
- Scavenging of hydrogen peroxide--a new mechanism of action for D-penicillamine in rheumatoid arthritis? Staite, N.D., Zoschke, D.C., Messner, R.P. N. Engl. J. Med. (1984)
- Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes. Lipsky, P.E. J. Clin. Invest. (1984)
- Toxic hepatitis after therapeutic doses of benorylate and D-penicillamine. Sacher, M., Thaler, H. Lancet (1977)
- TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Goldman, M., Druet, P., Gleichmann, E. Immunol. Today (1991)
- Beneficial effect of intravenous cyclophosphamide and oral prednisone on D-penicillamine-associated bronchiolitis obliterans. van de Laar, M.A., Westermann, C.J., Wagenaar, S.S., Dinant, H.J. Arthritis Rheum. (1985)
- Methotrexate therapy in rheumatoid arthritis: 15 years experience. Hoffmeister, R.T. Am. J. Med. (1983)
- Controlled trial of synthetic D-penicillamine and prednisone in maintenance therapy for active chronic hepatitis. Stern, R.B., Wilkinson, S.P., Howorth, P.J., Williams, R. Gut (1977)
- The effect of D-penicillamine on polymorphonuclear leukocyte function. Chwalinska-Sadowska, H., Baum, J. J. Clin. Invest. (1976)
- Pregnancy and cystinuria. Gregory, M.C., Mansell, M.A. Lancet (1983)
- Captopril: a new treatment for rheumatoid arthritis? Martin, M.F., Surrall, K.E., McKenna, F., Dixon, J.S., Bird, H.A., Wright, V. Lancet (1984)
- Prevention of spontaneous hepatocellular carcinoma in Long-Evans cinnamon rats with hereditary hepatitis by the administration of D-penicillamine. Jong-Hon, K., Togashi, Y., Kasai, H., Hosokawa, M., Takeichi, N. Hepatology (1993)
- Inhibition of human helper T cell function in vitro by D-penicillamine and CuSO4. Lipsky, P.E., Ziff, M. J. Clin. Invest. (1980)
- D-penicillamine-induced myasthenia gravis in primary biliary cirrhosis. Marcus, S.N., Chadwick, D., Walker, R.J. Gastroenterology (1984)
- Immunostimulant therapy with levamisole for rheumatoid arthritis. Huskisson, E.C., Scott, J., Balme, H.W., Dieppe, P.A., Trapnell, J., Willoughby, D.A. Lancet (1976)
- Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study. Jeurissen, M.E., Boerbooms, A.M., van de Putte, L.B., Doesburg, W.H., Lemmens, A.M. Ann. Intern. Med. (1991)
- Comparative inhibitory effects of bucillamine and D-penicillamine on the function of human B cells and T cells. Hirohata, S., Lipsky, P.E. Arthritis Rheum. (1994)
- Temporal patterns of response to D-penicillamine, hydroxychloroquine, and placebo in juvenile rheumatoid arthritis patients. van Kerckhove, C., Giannini, E.H., Lovell, D.J. Arthritis Rheum. (1988)
- Which traditional measures should be used in rheumatoid arthritis clinical trials? Anderson, J.J., Felson, D.T., Meenan, R.F., Williams, H.J. Arthritis Rheum. (1989)
- Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin. Nierkens, S., Aalbers, M., Bol, M., Bleumink, R., van Kooten, P., Boon, L., Pieters, R. J. Immunol. (2005)
- Selective requirement for CD40-CD154 in drug-induced type 1 versus type 2 responses to trinitrophenyl-ovalbumin. Nierkens, S., van Helden, P., Bol, M., Bleumink, R., van Kooten, P., Ramdien-Murli, S., Boon, L., Pieters, R. J. Immunol. (2002)
- D-penicillamine in dermatology: influence on enzymatic activities of human skin in vitro. Raab, W., Gmeiner, B. Archives for dermatological research. Archiv für dermatologische Forschung. (1975)
- KE-758, an active metabolite of the new anti-rheumatic drug KE-298, suppresses production of tumor necrosis factor-alpha and interleukin-1 beta in THP-1, a human monocyte cell line. Sugimoto, M., Inoue, T., Yamashita, M., Takeshita, K., Nakaike, S. Drugs under experimental and clinical research. (2002)
- Complement C4 null alleles as a marker of gold or D-penicillamine toxicity in the treatment of rheumatoid arthritis. Clarkson, R.W., Sanders, P.A., Grennan, D.M. Br. J. Rheumatol. (1992)
- Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Maier-Dobersberger, T., Mannhalter, C., Rack, S., Granditsch, G., Kaserer, K., Korninger, L., Steindl, P., Gangl, A., Ferenci, P. Gastroenterology (1995)
- D-Penicillamine-induced Goodpasture's-like syndrome in primary biliary cirrhosis--successful treatment with plasmapheresis and immunosuppressives. Matloff, D.S., Kaplan, M.M. Gastroenterology (1980)
- Effects of anticopper therapy on hepatocellular mitochondria in patients with Wilson's disease: an ultrastructural and stereological study. Sternlieb, I., Feldmann, G. Gastroenterology (1976)
- Fulminant Wilson's disease treated with postdilution hemofiltration and orthotopic liver transplantation. Rakela, J., Kurtz, S.B., McCarthy, J.T., Ludwig, J., Ascher, N.L., Bloomer, J.R., Claus, P.L. Gastroenterology (1986)